Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

ment for hepatitis C patients with unmet needs, including patients co-infected with HIV and HCV, African Americans, patients with cirrhosis, and patients who have failed to respond to previous therapy.

Important Safety Information about PEGASYS

PEGASYS, alone or in combination with COPEGUS, is indicated for the treatment of adults with chronic hepatitis C virus infection who have compensated liver disease and have not been previously treated with interferon alpha. Patients in whom efficacy was demonstrated included patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A).

Alpha interferons, including PEGASYS(R) (Peginterferon alfa-2a), may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Therapy should be withdrawn in patients with persistently severe or worsening signs or symptoms of these conditions. In many, but not all cases, these disorders resolve after stopping PEGASYS therapy (see CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS in complete product information).

Use with Ribavirin. Ribavirin, including COPEGUS(R), may cause birth defects and/or death of the fetus. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with ribavirin therapy may result in a worsening of cardiac disease. Ribavirin is genotoxic and mutagenic and should be considered a potential carcinogen (see CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS in complete product information).

PEGASYS is contraindicated in patients with hypersensitivity to PEGASYS or any of its components, autoimmune hepatitis, and hepatic decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients before or during tre
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Levi & Korsinsky ... Inc. (NASDAQ: OHRP ) concerning possible violations of ... by the Company in connection with its study of ... http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact Joseph E. Levi, ... or by telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
(Date:3/27/2015)... -- Holographic Optical Technologies of Augusta, Georgia ... is entering the world of consumer electronics with the ... th , 2015, the campaign will introduce the company,s ... displays will allow consumers to view fully three dimensional ... to the two displays, the company will also offer ...
(Date:3/27/2015)... -- A new report from Kalorama Information says that other ... Chile , Colombia and ... firms.  The healthcare research firm said that while ... Latin American continent with a population of over 200 million ... the country,s regional economic clout does not necessarily ensure its ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) has ... significantly oversubscribed. The issue price under the Placement ... price of QRxPharma shares on 28 September 2010 of A$1.00. ... oversubscriptions from investors and increase the size of the placement from ...
... Radio (Nasdaq: SIRI ) today announced that Andrew ... Center, will host the next edition of his Doctor Radio ... on the link between early antibiotic use in children and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) Dr. Brotman,s guests will ...
Cached Medicine Technology:QRxPharma Limited Announces A$14 Million Placement Together With a Share Purchase Plan 2QRxPharma Limited Announces A$14 Million Placement Together With a Share Purchase Plan 3SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 2SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 3SIRIUS XM's Doctor Radio's 'The Dean's List' To Focus On Link Between Early Antibiotic Use In Children And Obesity 4
(Date:3/27/2015)... Operatic contenders and their avid audience will be ... universally acclaimed baritone Sherrill Milnes will be overseeing the ... The Merion in Evanston. The event is the culmination ... singers from around the country. “This is a highly-anticipated ... talent in the country,” said Margaret Gergen, executive director ...
(Date:3/27/2015)... 2015 Approximately 300 advocates participated ... Coalition Lobby Day to lobby for physical education, ... (SHIP). Everlast Climbing was especially interested in ... which would strengthen physical education programs by adopting ... other measures to strengthen physical education in schools. ...
(Date:3/27/2015)... 2015 Airy Jeanine is a rising ... music video for her debut song “Mama’s Girl”, launched ... and abstract styling effects, the thematic video for the ... Vimeo, and assorted outlets. It will be integral in ... expanding full-scale marketing strategy. The video promotion campaign spearheaded ...
(Date:3/27/2015)... Newport, RI (PRWEB) March 27, 2015 April ... civil war – the Sesquicentennial. To honor America’s bloodiest war ... the Fort Adams Trust presents A Tribute to the Civil ... 7:00 PM, Friday, April 17, 2015, at the Jane Pickens ... Williams, noted Civil War-Lincoln scholar, will serve as the master ...
(Date:3/27/2015)... March 27, 2015 The Florida Center ... Brain Cancer Cure (ABC2), awarded $350,000 to support brain ... Florida, The Scripps Research Institute and H. Lee Moffitt ... studies with a clear development path and potential to ... the near future. , The awards fund research ...
Breaking Medicine News(10 mins):Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3
... study of its kind, researchers led by The University ... how hospital nurses actually use bar-coded technology that matches ... right medication. The surprising result is that the design ... upon as a "cure-all" for medication administration errors, is ...
... when key cellular signals run amok, driving uncontrolled cell ... Medicine report that lowering levels of one cancer signal ... returning tumor cells to their normal, healthy state. The ... minimizing side effects for the body,s healthy cells. , ...
... World Congress Center, Atlanta, Georgia, "Elimination ... of Health Professionals", WASHINGTON, July 1 ... National Medical Association:, WHAT: The nation,s ... issues affecting minority and underserved populations, the ...
... Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) announced today ... granted final approval for the Company,s,Abbreviated New Drug ... 25 mg, 50 mg, 75 mg, 100 mg, ... antidepressant. Its use is indicated,to treat symptoms of ...
... market, NORTH HOLLYWOOD, Calif., June 30 ... a leading national physician,group practice company, announced today ... acquisition expands IPC,s established,presence in the Dallas-Fort Worth ... of IPC, said, "The acquisition of,T.I.P.S. continues to ...
... or renovated rooms; Unity and ... ROCHESTER, N.Y., June 30 The state should,support plans ... 140 beds -- more than 50 of which could be ... a commission convened by,Finger Lakes Health Systems Agency., The ...
Cached Medicine News:Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 2Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 3Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 4Health News:Cancer cells revert to normal at specific signal threshold, Stanford researchers find 2Health News:Cancer cells revert to normal at specific signal threshold, Stanford researchers find 3Health News:National Medical Association Hosts the 2008 Annual Convention and Scientific Assembly 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R) 2Health News:IPC The Hospitalist Company Acquires Texas Inpatient Services 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 2Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 3Health News:2020 Commission Supports Modernization Plans at Three Monroe County Hospitals, With 140 Additional Beds 4
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
Its generous filter placement, MicroPoint design, and reference marks at 10, 50, and 100 ul make this ART tip ideal for many 200 ul pipettors....
... tips, microfuge tubes and PCR tubes. ... RNase- and DNase-free. Tubes have a ... 120°C. Available in a variety of ... a low binding surface. PCR Tubes ...
Medicine Products: